En bref: Vertex, Sandoz, Naobios, Pfizer

2023-12-15 15:00:00 Vertex signs licensing agreement with Editas Medicine Vertex has just signed a licensing agreement with the American biotech Editas Medicine for its Cas9 gene editing technology, CRISPR scissors. This agreement includes Casgevy (exagamglogene autotemcel), a cell therapy from Vertex approved in early December by the FDA against sickle cell disease. Thanks to this … Read more

CDMOs, collateral victims of disaffection for the Covid-19 vaccine?

2023-12-01 07:55:00 What remains of the unprecedented production effort launched during the Covid-19 pandemic? In 2021, CDMOs benefited from an unprecedented spotlight during the health crisis, with the production of the mRNA vaccine. Two years later, the record volumes requested to cope with the massive vaccination campaigns fizzled out. And push subcontractors to adapt. Latest … Read more

En bref : Boehringer Ingelheim, Bioxodes, EuroAPI

2023-11-23 15:00:00 Oncologie : Boehringer Ingelheim s’offre T3 Pharma pour 467 M€ The German laboratory announced the acquisition of the Swiss biotech company specializing in immuno-oncology, T3 Pharma. To do this, Boehringer Ingelheim will spend 450 million Swiss francs (€467 million). Founded in 2015, T3 Pharma has developed a platform using bacteria Yersinia enterocolitica which … Read more

Refocused on fine chemicals at its Pithiviers and Grasse sites, Axyntis returns to growth

2023-11-07 07:00:00 L’USINENOUVELLE.comleader in B2B professional information, offers you the opportunity to follow economic and industrial news from the automotive and new mobility, aeronautics and space, agri-food, energy and sustainable development, health, cosmetics and luxury, chemistry, transport, construction and defense sectors. , plastics processing, metallurgy, raw materials and materials, consumer goods, electronics, IT, telecommunications, cybersecurity, … Read more

Karl Rotthier leaves the general management of EuroAPI

2023-10-26 07:39:00 The EuroAPI Board of Directors terminated the functions of the Director General, Karl Rotthier, as of October 30, 2023. In replacement and on an interim basis, the current President of the Board of Directors, Viviane Monges, was appointed Director General and will combine both functions, pending a lasting solution. The group’s stock market … Read more

Bioplus-Interpex Korea 2023 held… CDMO and FDA regulations at a glance

2023-07-12 03:48:00 Bioplus-Interpex Korea 2023 was held at COEX in Gangnam-gu, Seoul with the theme of ‘Revamping the Industry’. The global comprehensive bio convention ‘Bioplus-Interpex Korea 2023 (hereinafter referred to as BIX 2023)’ was held at COEX, Gangnam-gu, Seoul on the 12th and 14th. BIX 2023 is co-hosted by the Korea Bio Association and RX … Read more